GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » EBITDA Margin %

Neutra (Neutra) EBITDA Margin % : -4,400.00% (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Neutra's EBITDA for the three months ended in Oct. 2023 was $-0.04 Mil. Neutra's Revenue for the three months ended in Oct. 2023 was $0.00 Mil. Therefore, Neutra's EBITDA margin for the quarter that ended in Oct. 2023 was -4,400.00%.


Neutra EBITDA Margin % Historical Data

The historical data trend for Neutra's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra EBITDA Margin % Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -5,916.67 -3,870.00 -538.04 -613.24

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -200.00 -3,933.33 -850.00 -1,475.00 -4,400.00

Competitive Comparison of Neutra's EBITDA Margin %

For the Biotechnology subindustry, Neutra's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Neutra's EBITDA Margin % falls into.



Neutra EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Neutra's EBITDA Margin % for the fiscal year that ended in Jan. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=-0.417/0.068
=-613.24 %

Neutra's EBITDA Margin % for the quarter that ended in Oct. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Oct. 2023 )/Revenue (Q: Oct. 2023 )
=-0.044/0.001
=-4,400.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Neutra EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Neutra's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243